Patents

Symbios has protected its inventions and technologies by filing six patent applications, with the core technology being protected under U.S. Patent 9,346,691, issued May 24, 2016.

For Healthcare applications, Symbios has been awarded patent protection for Electrochemical Plasma Activated Aqueous Chemotherapeutics under U.S. Patent 10,610,590, issued April 7, 2020.

As new intellectual property is developed through the engineering and commercialization process, the company’s patent strategy will be implemented and additional patents filed for both water treatment clean technology and bioscience advanced industry applications.